Abstract
S455 Efficacy and Safety of the Selective Sphingosine 1-Phosphate Receptor Modulator, Etrasimod, in Adult Patients With Eosinophilic Esophagitis: Primary Results From the Phase 2 VOYAGE Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have